| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.991 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.991 |
| Total Expenses - EUR | 107 | 11 | 0 | 0 | 0 | 0 | 0 | 59.238 | 0 | 1.817 |
| Gross Profit/Loss - EUR | -107 | -11 | 0 | 0 | 0 | 0 | 0 | -59.238 | 0 | 7.174 |
| Net Profit/Loss - EUR | -107 | -11 | 0 | 0 | 0 | 0 | 0 | -59.238 | 0 | 6.026 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Pharmavip Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 939 | 929 | 914 | 897 | 879 | 863 | 844 | 846 | 844 | 839 |
| Current Assets | 88.681 | 87.765 | 86.280 | 84.696 | 83.056 | 81.482 | 79.675 | 20.633 | 20.571 | 19.183 |
| Inventories | 88.427 | 87.525 | 86.044 | 84.465 | 82.829 | 81.259 | 79.457 | 20.465 | 20.403 | 19.021 |
| Receivables | 56 | 56 | 55 | 54 | 53 | 52 | 51 | 0 | 0 | 21 |
| Cash | 197 | 184 | 181 | 178 | 174 | 171 | 167 | 168 | 167 | 141 |
| Shareholders Funds | 11.793 | 11.661 | 11.464 | 11.254 | 11.036 | 10.827 | 10.586 | -48.619 | -48.471 | -42.174 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 77.827 | 77.033 | 75.729 | 74.340 | 72.900 | 71.518 | 69.932 | 70.098 | 69.886 | 62.196 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "148 - 148" | |||||||||
| CAEN Financial Year |
149
|
|||||||||
Comments - Pharmavip Srl